Cafepharma Today

April 26 2024 - Why the obesity drug market is about to get a lot more crowded
Why the obesity drug market is about to get a lot more crowded
Pfizer hemophilia gene therapy arrives in US to uncertain future
AbbVie lifts profit forecast after Skyrizi sales beat expectations
Walgreens rolls out gene, cell therapy services
*please scroll down for all the latest news*

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Why the obesity drug market is about to get a lot more crowded
Medical Marketing and Media
Friday, April 26, 2024 - 11:49am
tags:
obesity, Novo Nordisk, Wegovy, Eli Lilly, Zepbound, Roche, AstraZeneca
As Lilly and BMS invest in manufacturing, demand for drugs still outweighs supply
Pharma Voice
Friday, April 26, 2024 - 11:47am
tags:
drug shortages, drug manufacturing, Eli Lilly, Bristol Myers Squibb
Edwards Lifesciences beats the Street in Q1 and increases sales outlook
Mass Device
Friday, April 26, 2024 - 11:46am
tags:
Medtech, earnings, Edwards Lifesciences
Takeda ditches industry trade group BIO following exits by WuXi AppTec, Pfizer and UCB
Fierce Pharma
Friday, April 26, 2024 - 11:44am
tags:
Pfizer, UCB Pharma, WuXi AppTec, Takeda, BIO
Key opinion leaders on GLP-1 receptor agonist clinical trial design
Clinical Trials Arena
Friday, April 26, 2024 - 11:41am
tags:
clinical trials, GLP-1 agonist, type 2 diabetes, obesity
AbbVie's Rinvoq conquers Regeneron and Sanofi's Dupixent in eczema trial—again
Fierce Pharma
Friday, April 26, 2024 - 11:18am
tags:
AbbVie, Rinvoq, Regeneron, Sanofi, Dupixent, atopic dermatitis
Gilead Touts 5% Revenue Jump, Positions for 2024 Growth and Culls Pipeline
BioSpace
Friday, April 26, 2024 - 11:17am
tags:
Gilead Sciences, earnings
Bristol Myers Squibb closes immuno-oncology, cell therapy-focused Redwood City site
Fierce Biotech
Friday, April 26, 2024 - 11:16am
tags:
Bristol Myers Squibb, immuno-oncology, cell therapy, R&D, layoffs
Pfizer hemophilia gene therapy arrives in US to uncertain future
BioPharma Dive
Friday, April 26, 2024 - 11:15am
tags:
Pfizer, gene therapy, FDA, hemophila B, Beqvez
AbbVie lifts profit forecast after Skyrizi sales beat expectations
Reuters
Friday, April 26, 2024 - 11:12am
tags:
AbbVie, earnings
Owlstone secures $6.5M for breath-based diagnostics for infectious disease
Pharmaphorum
Friday, April 26, 2024 - 11:10am
tags:
Owlstone Medical, Gates Foundation, funding, diagnostics, breath-based diagnostics
Cigna’s Evernorth to Offer Humira Biosimilar with No Out-of-Pocket Cost
BioSpace
Friday, April 26, 2024 - 11:09am
tags:
Cigna, Evernorth Health, Accredo, AbbVie, Humira, biosimilars
European Commission approves Astellas’ drug for expanded prostate cancer Treatment
Outsourcing Pharma
Thursday, April 25, 2024 - 5:59pm
tags:
Astellas, Xtandi, Europe, prostate cancer
Germany's Merck breaks ground on $321m biomanufacturing center
BioProcess International
Thursday, April 25, 2024 - 5:57pm
tags:
Merck KGaA, drug manufacturing, Germany
Sanofi and AstraZeneca Scrap Several Early-Stage Programs in Q1
BioSpace
Thursday, April 25, 2024 - 5:56pm
tags:
Sanofi, AstraZeneca
Labcorp to acquire Invitae’s assets for $239M
Medtech Dive
Thursday, April 25, 2024 - 5:52pm
tags:
LabCorp, M&A, Invitae, diagnostics, Medtech
Walgreens rolls out gene, cell therapy services
Beckers Hospital Review
Thursday, April 25, 2024 - 5:51pm
tags:
Walgreens, cell therapy, gene therapy, Walgreens Specialty Pharmacy
Sanofi profit slips on generic competition and currency effects
Reuters
Thursday, April 25, 2024 - 5:47pm
tags:
Sanofi, earnings, generics
BMS to cut 2,200 jobs in $1.5B restructuring as Opdivo sales drop in Q1
BioSpace
Thursday, April 25, 2024 - 11:44am
tags:
Bristol Myers Squibb, earnings, Opdivo, layoffs
AstraZeneca leaps after smashing first-quarter forecasts
Reuters
Thursday, April 25, 2024 - 11:42am
tags:
AstraZeneca, earnings

Pages

Latest CP Wire Articles

PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies
Sapio Sciences launches new drug discovery platform
Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics
Why Medical and Pharma Sales Reps Should Start Their Own Senior Care Business
Bend Bioscience Adds Capacity and Technology Offerings with the Addition of New Process and Manufacturing Science Facility
Eastman introduces new excipient to formulate poorly soluble API

Latest Pharmagather Articles

How GoodRx is Evolving Its Reimbursement Approaches to Help Pharmacies and Consumers
Drug Channels
The Top 15 Specialty Pharmacies of 2023: Market Shares and Revenues at the Biggest PBMs, Health Plans, and Independents
Drug Channels
How Patient Engagement Can Reduce Brand Launch Risks
Drug Channels
The Top Pharmacy Benefit Managers of 2023: Market Share and Trends for the Biggest Companies—And What’s Ahead
Drug Channels
SAVE THE DATE: Drug Channels Leadership Forum, March 17-19, 2025
Drug Channels
Tales of the Unsurprised: U.S. Brand-Name Drug Prices Fell for an Unprecedented Sixth Consecutive Year—And Will Fall Further in 2024 (rerun)
Drug Channels
Vertical Integration Lessons: The Economics and Strategies of Hospital-Owned Specialty Pharmacies (rerun)
Drug Channels
The Big Three PBMs’ 2024 Formulary Exclusions: Biosimilar Humira Battles, CVS Health’s Weird Strategy, and the Insulin Shakeup (rerun)
Drug Channels
What CVS Pharmacy’s New Cost-Plus Reimbursement Approach Means for PBMs, Pharmacies, Plan Sponsors, and Prescription Prices (rerun)
Drug Channels

Latest Jobs

Account Executive - Hospice
Kansas City, MO, 64190
Agape Care Group
Area Manager-Specialty Mid-South
Fields, OR, 97710
CSL Behring
Account Executive - Hospice
Garden City, MO, 64747
Agape Care Group
Account Executive - Hospice
Holden, MO, 64040
Agape Care Group
Account Executive - Hospice
Harrisonville, MO, 64701
Agape Care Group
Account Executive - Hospice
Freeman, MO, 64746
Agape Care Group
Account Executive - Hospice
Higginsville, MO, 64037
Agape Care Group
Area Manager, Immunology West
Coffeyville, KS, 67337
CSL Behring
Area Manager-Immunology Southeast
Fields, OR, 97710
CSL Behring
Area Manager-Specialty, Delaware Valley
Fields, OR, 97710
CSL Behring
more jobs

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.

Do Not Allow Advertisers to Use My Personal information